非甲非乙型肝炎患者及艾滋病病毒风险人群中的丙型肝炎抗体（初步研究）
[Hepatitis C antibodies in non-A, non-B hepatitis patients and members of HIV risk groups (pilot study)].
作者信息
Kühnl P, Roggendorf M, Stangel W, Seidl S, Laufs R, Sibrowski W, Bornhövd K, Polywka S, Kalmar G, Deinhardt F
机构信息
Abt. f. Transfusionsmedizin u. Transplantationsimmunologie, Univ.-Klinik Hamburg.
出版信息
Beitr Infusionsther. 1990;26:30-2.
In a multi-center study sera from NANB-hepatitis (NANBH) patients and members of so-called HIV-risk groups (homosexuals, i.v.-drug abusers, hemophiliacs) were investigated by the recombinant-based HCV-antibody EIA, 74.4% of chronic NANBH-patients and 20% of acute NANBH patients were anti-HCV reactive, 33.3% of HIV-1-positive homosexuals, 43.5% of i.v.-drug abusers and 73.5% of hemophiliacs. The true prevalence of infection remains to be determined by a second, independent (confirmatory) test.
在一项多中心研究中，采用基于重组技术的丙型肝炎病毒（HCV）抗体酶免疫测定法（EIA），对非甲非乙型肝炎（NANBH）患者以及所谓的艾滋病病毒（HIV）高危人群（同性恋者、静脉注射吸毒者、血友病患者）的血清进行了检测。慢性NANBH患者中有74.4%、急性NANBH患者中有20%抗HCV呈反应性；HIV-1阳性的同性恋者中有33.3%、静脉注射吸毒者中有43.5%以及血友病患者中有73.5%抗HCV呈反应性。感染的实际流行率仍需通过第二种独立的（确证性）检测来确定。
Zotero 插件